ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,090,225 | +120101.2% | 58,525 | +167114.3% | 0.00% | – |
| Q2 2023 | $907 | -56.7% | 35 | -52.1% | 0.00% | – |
| Q1 2023 | $2,095 | +4.8% | 73 | +2.8% | 0.00% | – |
| Q4 2022 | $2,000 | -98.9% | 71 | -99.1% | 0.00% | – |
| Q3 2022 | $180,000 | +39.5% | 7,553 | +30.5% | 0.00% | – |
| Q2 2022 | $129,000 | +163.3% | 5,786 | +195.5% | 0.00% | – |
| Q1 2022 | $49,000 | -23.4% | 1,958 | +8.2% | 0.00% | – |
| Q4 2021 | $64,000 | -7.2% | 1,810 | +9.6% | 0.00% | – |
| Q3 2021 | $69,000 | +165.4% | 1,652 | +169.1% | 0.00% | – |
| Q2 2021 | $26,000 | +2500.0% | 614 | +1515.8% | 0.00% | – |
| Q1 2021 | $1,000 | -98.6% | 38 | -97.5% | 0.00% | – |
| Q4 2020 | $69,000 | +430.8% | 1,550 | +318.9% | 0.00% | – |
| Q3 2020 | $13,000 | 0.0% | 370 | +3.9% | 0.00% | – |
| Q2 2020 | $13,000 | -13.3% | 356 | -26.7% | 0.00% | – |
| Q1 2020 | $15,000 | – | 486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |